Erythroderma Following Fluphenazine Decanoate Injection: A Rare Adverse Drug Reaction in a Resource‐Limited Setting
Clinical Case Reports · 2026-11 · 14 (11)
DOI: 10.1002/ccr3.73938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 15.11.2026. Verfasst von Filmon Tesfay Riesehaymanot und 2 weiteren Autor:innen. Beteiligte Einrichtung: Keren Zonal Referral Hospital Keren Eritrea. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fluphenazine may rarely cause severe erythroderma. Early recognition, prompt discontinuation of the offending drug, and supportive management are essential to prevent serious complications, particularly in resource‐limited settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Keren Zonal Referral Hospital Keren Eritrea.
- Afabet Hospital Afabet Eritrea.
- Mendefera Zonal Referral Hospital Mendefera Eritrea.
ORCID-Profile: Filmon Tesfay Riesehaymanot
Zitieren
APA
Riesehaymanot, F. T., Tekeste, L. M., & Berhe, N. D. (2026). Erythroderma Following Fluphenazine Decanoate Injection: A Rare Adverse Drug Reaction in a Resource‐Limited Setting. Clinical Case Reports, 14(11). https://doi.org/10.1002/ccr3.73938
Vancouver
Riesehaymanot FT, Tekeste LM, Berhe ND. Erythroderma Following Fluphenazine Decanoate Injection: A Rare Adverse Drug Reaction in a Resource‐Limited Setting. Clinical Case Reports. 2026;14(11). doi:10.1002/ccr3.73938
BibTeX
@article{Riesehaymanot2026,
author = {Riesehaymanot, Filmon Tesfay and Tekeste, Lidya Musie and Berhe, Nahom Daniel},
title = {Erythroderma Following Fluphenazine Decanoate Injection: A Rare Adverse Drug Reaction in a Resource‐Limited Setting},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {11},
doi = {10.1002/ccr3.73938}
}
EUVIMED